21Jul GlaxoSmithKline Pharmaceuticals informPursuant to Regulations 29 & 33 of the Listing Obligations and Discl..
25Jun GlaxoSmithKline Pharmaceuticals inforGlaxoSmithKline Pharmaceuticals has informed that the Company has receiv..
08Jun GlaxoSmithKline Pharmaceuticals infIn terms of the requirements of Regulation 36(1)(b) of the SEBI (Listing..
26May GlaxoSmithKline Pharmaceuticals inforIn compliance with the provisions of Regulation 24A of SEBI LODR Amendme..
21Apr GlaxoSmithKline Pharmaceuticals informIn compliance with Regulation 30 of Securities and Exchange Board of Ind..